A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Potassium cation
Theobromine
Cannabidiol may increase the excretion rate of Theobromine which could result in a lower serum level and potentially a reduction in efficacy.
Potassium cation
Terguride
Terguride may increase the vasoconstricting activities of Cannabidiol.
Potassium cation
Dihydroergocryptine
Dihydroergocryptine may increase the vasoconstricting activities of Cannabidiol.
Potassium cation
Dihydroergocristine
Dihydroergocristine may increase the vasoconstricting activities of Cannabidiol.
Potassium cation
Dihydroergocornine
Dihydroergocornine may increase the vasoconstricting activities of Cannabidiol.
Potassium cation
Sulfaphenazole
The metabolism of Cannabidiol can be decreased when combined with Sulfaphenazole.
Potassium cation
Medical Cannabis
The metabolism of Cannabidiol can be decreased when combined with Medical Cannabis.
Potassium cation
Nylidrin
The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Nylidrin.
Potassium cation
Methylenedioxyethamphetamine
The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Methylenedioxyethamphetamine.
Potassium cation
Mefenorex
The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Mefenorex.
Potassium cation
Prenalterol
The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Prenalterol.
Potassium cation
Tretoquinol
The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Tretoquinol.
Potassium cation
Fenozolone
The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Fenozolone.
Potassium cation
Tramazoline
The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Tramazoline.
Potassium cation
Racepinephrine
The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Racepinephrine.
Potassium cation
Synephrine
The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Synephrine.
Potassium cation
Etilefrine
The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Etilefrine.
Potassium cation
Isoxsuprine
The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Isoxsuprine.
Potassium cation
Tetryzoline
The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Tetryzoline.
Potassium cation
Clenbuterol
The risk or severity of Tachycardia can be increased when Cannabidiol is combined with Clenbuterol.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3